SCHEMBL24087950

SCHEMBL24087950

N#Cc1c(SCc2cc(O)no2)[nH]c(=O)c(Cl)c1C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.36
▸ HSD11B1 P28845 14/20 0.35
▸ ALDH1A1 P00352 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ TSHR P16473 1/20 0.31
▸ BIRC5 O15392 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ GLA P06280 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ CRHBP P24387 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ CRHR2 Q13324 1/20 0.31
▸ SERPINH1 P50454 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24088144 0.89 KDM4E (0.36) KDM4EHSD11B1ALDH1A1MAPTTSHR
SCHEMBL26847318 0.88 HSD11B1 (0.35) KDM4EHSD11B1ALDH1A1MAPTTSHR
SCHEMBL24087891 0.80 KDM4E (0.58) KDM4EALDH1A1MAPTTSHRMEN1
SCHEMBL26847323 0.76 KDM4E (0.35) KDM4EHSD11B1ALDH1A1MAPTTSHR
SCHEMBL20339549 0.73 HSD11B1 (0.34) KDM4EHSD11B1
SCHEMBL20339245 0.73 KDM4E (0.57) KDM4EHSD11B1ALDH1A1MAPTTSHR
SCHEMBL24087883 0.71 MEN1 (0.43) KDM4EALDH1A1MAPTTSHRMEN1
SCHEMBL20339499 0.70 CYP1A2 (0.47) KDM4EALDH1A1MAPTTSHRMEN1
SCHEMBL24087949 0.69 ALDH1A1 (0.44) KDM4EHSD11B1ALDH1A1MAPTTSHR
SCHEMBL20350882 0.67 KDM4E (0.38) KDM4EHSD11B1ALDH1A1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S R L (IT) 2021-12-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 KDM4E 1110/4885HSD11B1 1734/4885ALDH1A1 171/4885
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 KDM4E 1110/4885HSD11B1 1734/4885ALDH1A1 171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback